Efficacy of Cobas HPV testing for predicting grade 2+ cervical intraepithelial neoplasia in a cancer prevention center and a gynecologic oncology clinic: A single-institution experience.

Autor: Davaro E; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tinnirello AA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bevers TB; Cancer Prevention Center, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Milbourne A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bassett R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Stewart J; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Guo M; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Publikováno v: Cancer cytopathology [Cancer Cytopathol] 2024 Mar; Vol. 132 (3), pp. 152-160. Date of Electronic Publication: 2023 Dec 06.

Molecular testing opportunities on cytology effusion specimens: the pre-analytic effects of various body fluid cytology preparation methods on RNA extraction quality and targeted sequencing.

Autor: Sura GH; Department of Pathology and Genomic Medicine, Houston Methodist, Houston, Texas., Tran K; Departments of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Fu C; Departments of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Du L; Departments of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Marczyk M; Department of Data Science and Engineering, Silesian University of Technology, Gliwice, Poland; Yale Cancer Center, Yale University, New Haven, Connecticut., Martinez Y; Departments of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Tinnirello AA; Departments of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gould RE; Departments of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lau R; Departments of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Symmans WF; Departments of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: fsymmans@mdanderson.org.

Publikováno v: Journal of the American Society of Cytopathology [J Am Soc Cytopathol] 2023 Jan-Feb; Vol. 12 (1), pp. 10-19. Date of Electronic Publication: 2022 Sep 15.

Validation of cobas 4800 HPV assay in SurePath Papanicolaou specimens for cervical cancer screening.

Autor: Guo M; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: mguo@mdanderson.org., Shlyakhova N; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Khanna A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Tinnirello AA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Schmeler KM; Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hwang J; Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sturgis EM; Department of Head and Neck Surgery The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas., Stewart J; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Publikováno v: Journal of the American Society of Cytopathology [J Am Soc Cytopathol] 2021 Jul-Aug; Vol. 10 (4), pp. 399-405. Date of Electronic Publication: 2021 Apr 19.